A phase II trial of neoadjuvant chemotherapy with docetaxel,cisplatin and S-1 (DCS) for radically resectable advanced gastric carcinoma (KDOG 1001)
Not Applicable
Recruiting
- Conditions
- radically resectable advanced gastric carcinoma
- Registration Number
- JPRN-UMIN000003642
- Lead Sponsor
- Kitasato University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. Active synchronous malignancy 2. History of serious drug hypersensitivity 3. Severe pulmonary disease (interstitial pneumonia, pulmonary fibrosis, severe pulmonary emphysema or etc) 4. Severe heart disease (congestive heart failure, symptomatic ischemic heart disease, uncontrolled arrhythmia, or etc) 5. Severe mental disorders, neurological disease 6. Pregnant or lactation women, or women with the possibility of the pregnancy and men who want let to pregnancy 7. Patients who are judged inappropriate for the entry into this study by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rate of radical resection
- Secondary Outcome Measures
Name Time Method